Related Experiment Video
Updated: Jul 10, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
[Effect of hemoperfusion in treatment of children with acute poisoning]
Yan Gao1, Yi-Lu Chen, Fu Zhong
1Department of Nephrology, Guangzhou Children Hospital, Guangzhou 510120 China.
Insights
Hemoperfusion (HP) effectively reduces poison levels in children, shortening elimination half-life and accelerating clearance. This safe and effective therapy shows promise for treating acute poisoning in pediatric patients.
Area of Science:
- Pediatric Toxicology
- Critical Care Medicine
- Renal Replacement Therapy
Context:
- Accidents are a leading cause of death in children aged 1-14 in China, with poisoning being a significant factor.
- Acute poisoning in children necessitates effective and safe treatment modalities.
- Hemoperfusion (HP) is a potential extracorporeal detoxification technique.
Purpose:
- To evaluate the efficacy of hemoperfusion (HP) in treating acute poisoning in children.
- To analyze the pharmacokinetics of poisons during and after HP.
- To assess the impact of HP on hematological parameters, blood biochemistry, blood flow, and heparin dosage.
Summary:
- Thirty-five children with acute poisoning (Fluoroacetamide and Tetramine) underwent 1-3 sessions of HP.
- HP significantly reduced poison concentrations (FAM and TET) and shortened their elimination half-life (t½).
- Clinical symptoms improved in 94% of cases, with 77% recovering fully; temporary poison re-elevation occurred post-HP.
Impact:
- Hemoperfusion is demonstrated as a safe and effective treatment for acute poisoning in children.
- HP accelerates poison clearance, significantly reducing toxicant levels.
- Temporary reductions in platelets and erythrocytes were observed, with lower heparin dosage requirements in children compared to adults.
Objective:
In China, with the development of public health and medical treatment, accident became the first cause of death of children aged form 1 to 14 years, and poisoning became one of the main causes. The present study was conducted to investigate the efficacy of hemoperfusion (HP) on poisoning, and the pharmacokinetics of the poison during and after HP. The study was also to observe the effect of HP on blood cell and blood biochemistry, blood flow and dosage of heparin during HP in children.
Methods:
Thirty-five children with acute poisoning (including 26 boys and 9 girls aged from 10 months to 13 years, mean 3.35 +/- 2.50 years) were treated with HP for one to three times. Among them 12 children were treated with HP for two times and 4 children for three times. Two ml blood samples of 6 children with Fluoroacetamide (FAM) poisoning and 10 children with Tetramine (TET) poisoning were collected. The concentration of poison was measured by gas chromatography (GC).
Results:
The poisoning symptoms of all cases were relieved or alleviated obviously. In the end, 27 (77%) cases recovered and 6 (17%) cases improved, while 2 (6%) cases died of multi-organ failure (MOF). Clinical symptom happened again 6 - 24 hours after HP in 1 case with FAM poisoning and 3 cases with TET whose clinical symptoms were relieved during HP. The PLT, RBC counts and Hb decreased significantly after HP compared with pre-HP (P < 0.05), while WBC, alanine aminotransferase (ALT), aspartate aminotransferase (AST), reatine kinase (CK), blood urea nitrogen (BUN), creatinine (CRE), Creatine kinase isoenzymes (CK-MB), total protein (TP), albumin (ALB) and globulim (GLO) after HP did not significantly change (P > 0.05). The FAM concentration was significantly reduced (P < 0.030). The concentration of TET in the poisoned children also significantly decreased with the treatment (P = 0.001). The cleaning efficacy of HP was higher during the first hour than that during the second hour of HP. The concentration of poison rose again 2 - 6 hours after HP in 1 case with FAM poisoning and 3 cases with TET poisoning, but the level was lower compared with pre-HP level. The t(1/2) of FAM and TET with and without HP was (2.40 +/- 0.66) h, (15.60 +/- 8.22) h, (4.10 +/- 1.66) h and (67.01 +/- 48.42) h, respectively. The first dose of heparin was (0.54 +/- 0.15) mg/kg; then (0.20 +/- 0.06) mg/kg was added for every 30 minutes. The velocity of blood flow was (4.39 +/- 0.99) ml/min.
Conclusions:
The t(1/2) of the poison was shortened, and the poison clearing was accelerated by HP. The HP is a safe and effective therapy in children. The concentration of poison in some patient may rise again 2 to 6 hours after HP temporarily. The charcoal HP cannot remove the poison that conjugated with plasma albumin and globulin. The charcoal HP can cause temporary reduction of platelet and erythrocyte. The dosage of heparin used in children was lower than that in adult.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Pharmaceutical Poisoning: Treatment Strategies
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Prevention of Further Absorption of Poison
Pharmacokinetics in Pediatric Patients: Drug Metabolism
